Intrinsic Activating Properties of GP IIb/IIIa Blockers
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 103, S21-S27
- https://doi.org/10.1016/s0049-3848(01)00300-0
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trialJournal of the American College of Cardiology, 2000
- Long-Term Treatment with a Platelet Glycoprotein-Receptor Antagonist after Percutaneous Coronary RevascularizationNew England Journal of Medicine, 2000
- Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudyThe American Journal of Cardiology, 2000
- Bidirectional Transmembrane Modulation of Integrin αIIbβ3 ConformationsJournal of Biological Chemistry, 1999
- Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.Journal of Clinical Investigation, 1997
- Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusionThe American Journal of Cardiology, 1996
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992
- Cell adhesion to fibronectin and tenascin: quantitative measurements of initial binding and subsequent strengthening response.The Journal of cell biology, 1989
- Platelet glycoprotein IIb. Chromosomal localization and tissue expression.Journal of Clinical Investigation, 1987
- Integrins: A family of cell surface receptorsCell, 1987